Key statistics
As of last trade Ligand Pharmaceuticals Inc (LGDN:BER) traded at 95.00, -7.77% below its 52-week high of 103.00, set on Jul 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 95.00 |
---|---|
High | 95.00 |
Low | 95.00 |
Bid | 94.50 |
Offer | 95.50 |
Previous close | 92.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 18.27m |
Free float | 17.91m |
P/E (TTM) | 47.09 |
Market cap | 1.91bn USD |
EPS (TTM) | 2.22 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 07:08 BST.
More ▼
Press releases
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
- Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Ligand Reports Second Quarter 2024 Financial Results
- Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024